01.29.19
Parker Bioscience Filtration has enhanced its manufacturing capabilities with the launch of a new ISO class 7 cleanroom facility at its site in Birtley, UK.
The cleanroom, which opened this month, forms part of a major phased investment program at the Birtley site and will be dedicated to the manufacture of single-use assemblies used in biopharmaceutical manufacturing. The assemblies are supplied to customers fully assembled and pre-irradiated ready for direct use in their cleanroom facilities in the manufacture of drug products.
In tandem with the launch of the new cleanroom, the Birtley site will see the introduction of a new manufacturing area for single-use sensing technologies used in biopharmaceutical manufacturing. These allow users to monitor key process parameters such as temperature, pressure and conductivity.
With another manufacturing site in Oxnard, CA, Parker Bioscience Filtration supports companies in improving process control, efficiency and security throughout their production and packaging processes, and provides integrated bioprocessing solutions that speed up development times, increase efficiency and safety, and enable reproducible quality. Incorporating SciLog and domnick hunter, Parker Bioscience Filtration combines filtration, single-use fluid-handling systems and sensors into automated single-use solutions.
The new 600 square meter cleanroom will not only complement the existing cleanroom facilities but also provide additional manufacturing capacity for single-use technologies at the UK site, which already has 2400 square meters of cleanroom facilities dedicated to the manufacture of filtration products and the manufacture of single-use assemblies.
The new cleanroom, which will be completely dedicated to the manufacture of single-use assemblies, strengthens the Parker Bioscience Filtration’s ability to serve biopharmaceutical manufacturers in the European market and complements existing single-use assembly manufacturing operations in the U.S.
Once completed, the overall investment will also see an expansion of Parker Bioscience Filtration’s laboratory, office and warehouse facilities, and will make the Birtley premises one of the most modern manufacturing sites for integrated bioprocessing solutions in EMEA.
“The opening of a new ISO Class 7 cleanroom in Birtley will shorten the supply chain for our global customers and enhance our ability to meet growing market demand for single-use assemblies in the biopharmaceutical manufacturing sector,” said Mike Brailsford, general manager, Parker Bioscience Filtration. “Alongside other developments taking place at our UK site as part of the investment program, the launch of new cleanroom facility demonstrates Parker Hannifin’s commitment to our European customer base.”
The cleanroom, which opened this month, forms part of a major phased investment program at the Birtley site and will be dedicated to the manufacture of single-use assemblies used in biopharmaceutical manufacturing. The assemblies are supplied to customers fully assembled and pre-irradiated ready for direct use in their cleanroom facilities in the manufacture of drug products.
In tandem with the launch of the new cleanroom, the Birtley site will see the introduction of a new manufacturing area for single-use sensing technologies used in biopharmaceutical manufacturing. These allow users to monitor key process parameters such as temperature, pressure and conductivity.
With another manufacturing site in Oxnard, CA, Parker Bioscience Filtration supports companies in improving process control, efficiency and security throughout their production and packaging processes, and provides integrated bioprocessing solutions that speed up development times, increase efficiency and safety, and enable reproducible quality. Incorporating SciLog and domnick hunter, Parker Bioscience Filtration combines filtration, single-use fluid-handling systems and sensors into automated single-use solutions.
The new 600 square meter cleanroom will not only complement the existing cleanroom facilities but also provide additional manufacturing capacity for single-use technologies at the UK site, which already has 2400 square meters of cleanroom facilities dedicated to the manufacture of filtration products and the manufacture of single-use assemblies.
The new cleanroom, which will be completely dedicated to the manufacture of single-use assemblies, strengthens the Parker Bioscience Filtration’s ability to serve biopharmaceutical manufacturers in the European market and complements existing single-use assembly manufacturing operations in the U.S.
Once completed, the overall investment will also see an expansion of Parker Bioscience Filtration’s laboratory, office and warehouse facilities, and will make the Birtley premises one of the most modern manufacturing sites for integrated bioprocessing solutions in EMEA.
“The opening of a new ISO Class 7 cleanroom in Birtley will shorten the supply chain for our global customers and enhance our ability to meet growing market demand for single-use assemblies in the biopharmaceutical manufacturing sector,” said Mike Brailsford, general manager, Parker Bioscience Filtration. “Alongside other developments taking place at our UK site as part of the investment program, the launch of new cleanroom facility demonstrates Parker Hannifin’s commitment to our European customer base.”
